This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: City of Hope, Imugene Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 10 
1 out of 2 Years Active: 2026
Title: Saul J. Priceman: Inventor in Oncolytic Virus Research
Introduction
Saul J. Priceman is an inventor based in Valley Village, California. His patent work concerns oncolytic viruses and potential approaches to treating solid tumors.
Latest Patents
Priceman is associated with one patent, titled “Methods Comprising Oncolytic Viruses Expressing CD19T and Bispecific T Cell Engagers.” The patent describes oncolytic viruses expressing truncated human CD19 (CD19t) and methods for treating solid tumors by administering such a virus, optionally alongside a T-cell engager targeted to CD19.
Career Highlights
Priceman’s listed professional affiliations include City of Hope and Imugene Ltd. His patent reflects work at the intersection of oncolytic virus research and immune-based cancer treatment.
Collaborations
His listed collaborators include Anthony K. Park and Yuman Fong.
Conclusion
Saul J. Priceman’s patent focuses on combining oncolytic viruses expressing truncated CD19 with optional T-cell engagers as a potential strategy for treating solid tumors.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile